Department of ophthalmology, the General Hospital of Northern Theater Command, No.83, Wenhua Road, Shenhe District, 110840, Shenyang, China.
BMC Ophthalmol. 2022 Oct 5;22(1):396. doi: 10.1186/s12886-022-02609-2.
To compare the Ocular surface disease index (OSDI) score, Schirmer I test (SIT), fluorescein break up time (FBUT) and fluorescence staining (FLCS) score of dry eye patients at different ages.
90 eyes of 90 patients with mild to moderate dry eye from September 2020 to September 2021 were retrospectively included and were divided into young group (20-39 years, n = 29), middle-age group (40-59 years, n = 30), and elder group (> 60 years, n = 31). Patients were given a 28-day topical lubricating ocular surface and repair-promoting drugs combined with local physical therapy. Patients were followed up at 7, 14 and 28 days. The OSDI score, SIT, FBUT and FLCS score were examined.
There were differences between the OSDI score in three groups at each time point (all P < 0.001). SIT were different among the three groups (F = 350.61, P < 0.001), and a time effect was found (F = 80.87, P < 0.001). SIT at 14 and 28 days after treatment in middle-age and elder groups were lower than young group (all P < 0.001). SIT at 7, 14 and 28 days in elder group were lower than middle-age group (all P < 0.001). FLCS score was lower at 28 days than other time points (all P < 0.001).
Dry eye patients are given a 28-day topical lubricating ocular surface and repair-promoting drugs combined with local physical therapy, which can promote tear secretion, film stability, and the recovery of corneal integrity. Age affects the treatment effect of mild to moderate dry eye, among which tear secretion is the most significant.
比较不同年龄段干眼症患者的眼表疾病指数(OSDI)评分、泪液分泌试验(SIT)、泪膜破裂时间(FBUT)和荧光素染色(FLCS)评分。
回顾性纳入 2020 年 9 月至 2021 年 9 月期间 90 例轻中度干眼症患者的 90 只眼,分为青年组(20-39 岁,n=29)、中年组(40-59 岁,n=30)和老年组(>60 岁,n=31)。患者给予 28 天局部眼表润滑和修复促进药物联合局部物理治疗。分别于第 7、14、28 天进行随访,检查 OSDI 评分、SIT、FBUT 和 FLCS 评分。
三组患者各时间点 OSDI 评分均有差异(均 P<0.001)。三组患者 SIT 不同(F=350.61,P<0.001),且有时间效应(F=80.87,P<0.001)。治疗后 14、28 天,中、老年组 SIT 均低于青年组(均 P<0.001);治疗后 7、14、28 天,老年组 SIT 均低于中年组(均 P<0.001)。FLCS 评分在 28 天较其他时间点均降低(均 P<0.001)。
轻中度干眼症患者给予 28 天局部眼表润滑和修复促进药物联合局部物理治疗,可促进泪液分泌、提高泪膜稳定性、恢复角膜完整性。年龄影响轻中度干眼症的治疗效果,其中泪液分泌影响最明显。